C34H39N3O8 Cytidine, 5'-O-[bis (4-methoxyphenyl) phenylmethyl] -2'-O- (2-methox yethyl) -5-methyl- (9CI, ACI)

Canonical SMILES O=C1N=C(N)C(=CN1C2OC(COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)C(O)C2OCCOC)C
Isomeric SMILES C (OC [C @ H] 1O [C @ H] ([C @ H] (OCCOC) [C@@H] 1O) N2C (= O) N = C (N) C (C) = C2) (C3 = CC = C
InChi
InChi=1S/C34H39N3O8/c1-22-20-37(33(39)36-31(22)35)32-30(43-19) -18-40-2)29 (38)28 (45-32)21-44-34 (23-8-6-5-7-9-23,24-10-14-26(4) 1-3)15-11-24)25-12-16-27(42-4)17-13-25/h5-17,20,28-30,32,38H,18-19,21H2,1-4H3,(H2,35,36,39)/t2,35,36,39)/t28-1m
InChi Key
LYKTVJJXZQTNPK-PBAMLIMUSA-N
24 Wasu Sunaye na wannan Abu
5'-O-[Bis (4-methoxyphenyl) phenylmethyl] -2'-O- (2-methoxyethyl) -5-methylcytidine (ACI); 11: PN: US20030170636 SHAFI: 17 da'awar RNA; 12: PN: US20030211606 SHAFI: 18 da'awar R NA; 12: PN: US20030212017 SHAFI: 19 da'awar R NA; 14: PN: US20040005569 PAG E: 21 da'awar R NA; 15: PN: US20040005565 SHAFI: 17- 22 da'awar RNA; 15: PN: US20040005570 SHAFI: 19 da'awar R NA; 15: PN: U S20040006030 SHAFI: 22 da'awar R NA; 15: PN: US20040014048 SHAFI: 19 da'awar R NA; 16: PN: US20030171313 SHAFI: 9 da'awar RNA; 16: PN: US20030198965 SHAFI: 19 da'awar R NA; 16: PN: US20040014047 SHAFI: 19 da'awar R NA; 16: PN: US20040014049 SHAFI:

19 da'awar RNA; 17: PN: US20040014051 SHAFI: 21 da'awar R NA; 17: PN: US20040014699 SHAFI: 19 da'awar R NA; 17: PN: W
O03106645 SHAFI: 69 da'awar R NA; 18: PN: US20040006029 SHAFI: 22 da'awar R NA; 2'-O-Methoxyethyl-5'-O-dimethoxytrityl-5- methylcytidine; 58: PN: US20030166592 SHAFI: 15 da'awar R NA; 5: PN: WO2005006958 SHAFI: 61 da'awar R NA; 7: PN: WO20050 07825 SHAFI: 61 da'awar R NA; 82: PN: US20040171566 SHAFI: 18 da'awar R NA; 89: PN: US20040005707 SHAFI: 19 da'awar R NA; 9: PN: WO03084478 SHAFI: 56 da'awar R NA